Terpenoid ID | TKC151885 | |
Chirality | TKC001229 | |
Cell line | 0 | |
Protein target | 31 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 34 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC151885 | P11473 | Vitamin D3 receptor | VDR | 89125 | nM | Potency |
TKC151885 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 5174 | nM | Potency |
TKC151885 | O95398 | Rap guanine nucleotide exchange factor 3 | RAPGEF3 | 31623 | nM | Potency |
TKC151885 | P53350 | Serine/threonine-protein kinase PLK1 | PLK1 | 6702 | nM | Potency |
TKC151885 | P84022 | Mothers against decapentaplegic homolog 3 | SMAD3 | 12589 | nM | Potency |
TKC151885 | Q03431 | Parathyroid hormone/parathyroid hormone-related peptide receptor | PTH1R | 56234 | nM | Potency |
TKC151885 | Q99700 | Ataxin-2 | ATXN2 | 31623 | nM | Potency |
TKC151885 | O75164 | Lysine-specific demethylase 4A | KDM4A | 39811 | nM | Potency |
TKC151885 | Q962Y6 | Thioredoxin glutathione reductase | TGR | 2818 | nM | Potency |
TKC151885 | O75496 | Geminin | GMNN | 731 | nM | Potency |
TKC151885 | O89049 | Thioredoxin reductase 1, cytoplasmic | Txnrd1 | 15849 | nM | Potency |
TKC151885 | P37840 | Alpha-synuclein | SNCA | 25119 | nM | Potency |
TKC151885 | Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | APOBEC3G | 22387 | nM | Potency |
TKC151885 | P39748 | Flap endonuclease 1 | FEN1 | 89125 | nM | Potency |
TKC151885 | P83916 | Chromobox protein homolog 1 | CBX1 | 22387 | nM | Potency |
TKC151885 | P00811 | Beta-lactamase | ampC | 44668 | nM | Potency |
TKC151885 | Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | EHMT2 | 891 | nM | Potency |
TKC151885 | P08659 | Luciferin 4-monooxygenase | 19012 | nM | Potency | |
TKC151885 | O00255 | Menin | MEN1 | 12589 | nM | Potency |
TKC151885 | O97447 | Putative fructose-1,6-bisphosphate aldolase | fba | 5012 | nM | Potency |
TKC151885 | P02791 | Ferritin light chain | FTL | 15849 | nM | Potency |
TKC151885 | Q92830 | Histone acetyltransferase KAT2A | KAT2A | 39811 | nM | Potency |
TKC151885 | Q9F4F7 | 4'-phosphopantetheinyl transferase ffp | ffp | 3981 | nM | Potency |
TKC151885 | P29990 | Genome polyprotein | 84430 | nM | IC50 | |
TKC151885 | P49798 | Regulator of G-protein signaling 4 | RGS4 | 44668 | nM | Potency |
TKC151885 | P51450 | Nuclear receptor ROR-gamma | Rorc | 14125 | nM | Potency |
TKC151885 | Q27686 | Pyruvate kinase | PYK | 15849 | nM | Potency |
TKC151885 | P06492 | Tegument protein VP16 | UL48 | 39892 | nM | IC50 |
TKC151885 | Q9Y5X4 | Photoreceptor-specific nuclear receptor | NR2E3 | 2594 | nM | IC50 |
TKC151885 | P11413 | Glucose-6-phosphate 1-dehydrogenase | G6PD | >80000 | nM | IC50 |
TKC151885 | Q57TT1 | HpcH_HpaI domain-containing protein | Tb08.30K1.730 | 2239 | nM | Potency |
TKC151885 | Q9BHT9 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | G6PD-6PGL | 4950 | nM | IC50 |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P11473 | VDR_HUMAN | Chronic kidney disease [ICD-11: GB61] |
P11473 | VDR_HUMAN | Hair/hair growth developmental defect [ICD-11: LC30] |
P11473 | VDR_HUMAN | Hyper-parathyroidism [ICD-11: 5A51] |
P11473 | VDR_HUMAN | Hypo-parathyroidism [ICD-11: 5A50] |
P11473 | VDR_HUMAN | Mineral deficiency [ICD-11: 5B5K] |
P11473 | VDR_HUMAN | Psoriasis [ICD-11: EA90] |
P11473 | VDR_HUMAN | Vitamin deficiency [ICD-11: 5B55-5B5F] |
P11473 | VDR_HUMAN | Low bone mass disorder [ICD-11: FB83] |
P11473 | VDR_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P11473 | VDR_HUMAN | Prostate cancer [ICD-11: 2C82] |
P11473 | VDR_HUMAN | Prostate disease [ICD-11: GA91] |
P11473 | VDR_HUMAN | Abnormal micturition [ICD-11: MF50] |
P11473 | VDR_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11473 | VDR_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P11473 | VDR_HUMAN | Acne vulgaris [ICD-11: ED80] |
O95398 | RPGF3_HUMAN | Epidermal dysplasias [ICD-11: EK90] |
P53350 | PLK1_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P53350 | PLK1_HUMAN | Myelodysplastic syndrome [ICD-11: 2A37] |
P53350 | PLK1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P53350 | PLK1_HUMAN | Prostate cancer [ICD-11: 2C82] |
P53350 | PLK1_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P53350 | PLK1_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P53350 | PLK1_HUMAN | Lymphoma [ICD-11: 2A80-2A86] |
P53350 | PLK1_HUMAN | Nasopharyngeal cancer [ICD-11: 2B6B] |
P53350 | PLK1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P84022 | SMAD3_HUMAN | Herpes simplex infection [ICD-11: 1F00] |
P84022 | SMAD3_HUMAN | Kidney fibrosis [ICD-11: GC01] |
Q03431 | PTH1R_HUMAN | Low bone mass disorder [ICD-11: FB83] |
Q03431 | PTH1R_HUMAN | Hypo-parathyroidism [ICD-11: 5A50] |
P37840 | SYUA_HUMAN | Parkinsonism [ICD-11: 8A00] |
P37840 | SYUA_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P37840 | SYUA_HUMAN | Autonomic nervous system disorder [ICD-11: 8D87] |
Q96KQ7 | EHMT2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 | EHMT2_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 | EHMT2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11413 | G6PD_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
P11413 | G6PD_HUMAN | Chronic obstructive pulmonary disease [ICD-11: CA22] |
P11413 | G6PD_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |